Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 476

The DOI matches its Crossref record; 269 of the 269 references it cites were found in a registry or an index.

Base editing: advances and therapeutic opportunities

Open access
Porto, Elizabeth M., Komor, Alexis C., Slaymaker, Ian M., Yeo, Gene W.·2020·Nature Reviews Drug Discovery

Abstract

Base editing — the introduction of single-nucleotide variants (SNVs) into DNA or RNA in living cells — is one of the most recent advances in the field of genome editing. As around half of known pathogenic genetic variants are due to SNVs, base editing holds great potential for the treatment of numerous genetic diseases, through either temporary RNA or permanent DNA base alterations. Recent advances in the specificity, efficiency, precision and delivery of DNA and RNA base editors are revealing exciting therapeutic opportunities for these technologies. We expect the correction of single point mutations will be a major focus of future precision medicine. Base editing is emerging as a potential approach to treat genetic diseases through the introduction of single-nucleotide alterations in DNA and RNA. Here, Porto et al. provide an overview of DNA and RNA base editing, discuss recent advances in the development of these technologies and highlight promising therapeutic applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41573-020-0084-6

Cites

269 of 269 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 269 references

Cited by

See all 476

Metadata

Authors
Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W.
Venue
Nature Reviews Drug Discovery
Published
2020-10-19
Volume
19
Issue
12
Pages
839-859
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W3093469725
Cited by
476
References
269
FWCI
3.90
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Base editing: advances and therapeutic opportunities. https://app.cochat.ai/papers/10.1038/s41573-020-0084-6
The paper
Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020). Base editing: advances and therapeutic opportunities. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-020-0084-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.